Reimbursement

Latest News
July 15th 2025

For Community Oncology, Good News in PFS Offset by Potential Wreckage of MFP Proposal

July 14th 2025

Medicare Inflation Rebates Show Limited Impact on Drug Price Trends

July 8th 2025

Practical Considerations for AI in Community Oncology

July 7th 2025

How AI Can Address the Troubled Business Model in Oncology

July 5th 2025

At ASCO, Testing and AI Rival Drugs for Attention, but Reimbursement Remains a Barrier

Video Interviews
View All
July 10th 2025

RFK Jr Has Power to Remove USPSTF Members With Braidwood Decision: Jeffrey Fitzgerald, JD

July 7th 2025

Medina v Planned Parenthood Could Have Implications With Medicaid Funding: Jennifer Evans, JD

July 3rd 2025

Supreme Court Decision Marks a Failed Attempt at Attacking ACA: Jeffrey Fitzgerald, JD

July 2nd 2025

Medina v Planned Parenthood Case Reinterprets Any Willing Provider Provision: Jennifer Evans, JD

May 27th 2025

Oncology Advances Bring CAR T Local, but Community Practices Need Support: Nini Wu, MD

March 15th 2025

How Do Infusion Pharmacies Support Financial Sustainability in Oncology?

October 31st 2024

Legislation Can Help Increase Uptake of PDTs, Improve Reimbursement

October 20th 2024

EOM Improved Over OCM, but Challenges Remain for Practices

September 27th 2024

EOM Adjustments Make it Easier for Practices to Say “Yes” to Participation

September 11th 2024

The Challenge of Living in Both FFS and Value-Based Care Worlds

Podcasts
View All
March 26th 2024

Exploring Medicare Advantage Prior Authorization Variations

August 1st 2023

Oncology Onward: A Conversation With Dr Debra Patt of Texas Oncology

More News

Without IRA Fix, COA Warns Community Oncology Practices Will Shut Down
June 30th 2025

Without IRA Fix, COA Warns Community Oncology Practices Will Shut Down

Mary Caffrey
Ted Okon, MBA, of the Community Oncology Alliance discusses how community oncology faces a revenue crisis due to the Inflation Reduction Act's impact on Medicare reimbursement, risking patient access to vital cancer treatments.
Planned Parenthood | Image credit: William A. Morgan - stock.adobe.com
June 26th 2025

SCOTUS Rules Abortion Clinics Can Not Challenge South Carolina’s Medicaid Order

Julia Bonavitacola
South Carolina had previously barred abortion clinics, including Planned Parenthood, from participating in Medicaid, leaving many patients vulnerable to uncovered treatment.
Image provided by NCCN
May 7th 2025

NCCN Summit Seeks to Build Better Connections Between Oncology and Primary Care

Mary Caffrey
The National Comprehensive Cancer Network (NCCN) policy summit highlighted the need for improved communication between oncology and primary care to enhance cancer survivor outcomes and care transitions.
Patient navigation | Image credit: AON
April 22nd 2025

With Thyme Care Partnership, AON Achieves $6M in Savings in EOM’s First Performance Period

Mary Caffrey
inflation reduction act | Image credit: Vitalii Vodolazskyi -stock.adobe.com
April 2nd 2025

The IRA’s Unintended Consequences for Drug Pricing and Coverage

Skylar Jeremias
The Inflation Reduction Act (IRA) may be restricting Medicare Part D formularies, increasing patient costs, and stifling pharmaceutical innovation, experts warned at the Academy of Managed Care Pharmacy 2025 annual meeting.
Texas Oncology logo | Image: Texas Oncology
March 18th 2025

Texas Oncology to Roll Out Canopy for ePROs After Head-to-Head Pilot

Mary Caffrey Rose McNulty
Debra Patt, MD, PhD, MBA, executive vice president of Public Policy and Strategy for Texas Oncology, said the practice received positive feedback from nurses and patients during a pilot that concluded in February.
Kirollos Hanna, PharmD
January 29th 2025

Embracing EOM, Enhancing Collaboration and Cost Management: Dr Kirollos Hanna

Kyle Munz Kirollos Hanna, PharmD
The design of the Enhancing Oncology Model (EOM) was a perfect fit for Minnesota Oncology.
Class action book and gavel | Image credit: Zerbor – stock.adobe.com
November 5th 2024

GoodRx, PBMs Hit by Price Fixing Lawsuits

Hayden E. Klein
Independent pharmacies have filed 3 class action lawsuits against GoodRx Holdings and major pharmacy benefit managers (PBMs).
Screenshot of an interview with Stuart Staggs
October 27th 2024

The Challenge of Addressing Drug Spend to Drive Down Total Cost of Care in EOM

Laura Joszt, MA
Stuart Staggs, vice president of transformation and shared services at McKesson, explained that oncology practices in the Enhancing Oncology Model (EOM) have a tough job driving down costs when drug costs make up a larger portion of the total cost of care.
Stethoscope on money | Image credit: utah51 - adobe.stock.com
October 17th 2024

Pressure on Congress to Reform Medicare Physician Fee Schedule, Prevent Reimbursement Cuts

Laura Joszt, MA
A new letter signed by more than 230 members of the House urges Congress to not only block the scheduled 2.8% reimbursement cut, but also reform the Medicare Physician Fee Schedule.
MinnOncology logo | Image: Minnesota Oncology
October 14th 2024

The Daily Balancing Act of Value-Based Cancer Care

Laura Joszt, MA
Doing Things Differently: Wilfong Moves to Thyme Care
October 12th 2024

Doing Things Differently: Wilfong Moves to Thyme Care

Mary Caffrey
Lalan Wilfong, MD, a 20-year medical oncologist with Texas Oncology, is senior vice president, value-based care, Thyme Care.
Thyme Care logo | Image : Thyme Care
October 12th 2024

Beyond Navigation: Thyme Care Ready for Heavy Lifts to Make Value-Based Care Work

Mary Caffrey
AJMC
September 19th 2024

Care Transition Management and Patient Outcomes in Hospitalized Medicare Beneficiaries

Mariétou H. Ouayogodé, PhD Brianna Hardy, BS John Mullahy, PhD Maureen A. Smith, MD, PhD, MPH Ellen Meara, PhD
Hospital care transition activity facilitates uptake of Medicare-reimbursed transitional care management, which is associated with lower spending and better patient outcomes.
Avalere logo | Image credit: LinkedIn
September 17th 2024

Part B Losses to Oncologists Due to IRA Could Total $12B Through 2032 Across Medicare, Commercial Plans

Mary Caffrey
Based on an Avalere Health report, Community Oncology Alliance warns that IRA negotiations could slice down payments needed to administer cancer drugs.
While shares varied by payer market, 73.6% of retail prescriptions overall were attributed to CVS Caremark, Optum Rx, and Express Scripts in the study. | Image credit: DedMityay - stock.adobe.c
September 10th 2024

A Highly Concentrated PBM Market Highlights Need for Policy Changes

Rose McNulty
The findings may help inform policy changes at the federal level aiming to address unfair and deceptive pharmacy benefit manager (PBM) practices.
Nick Ferreyros of Community Oncology Alliance during a video interview
September 10th 2024

IRA Negotiated Drug Prices Can’t Come “On the Backs of Providers”

Alexandra Gerlach Laura Joszt, MA
There are concerns that the negotiated drug prices under the Inflation Reduction Act (IRA) are leading to large provider reimbursement cuts, explained Nick Ferreyros, managing director, Community Oncology Alliance.
The process for regulatory approvals varies by country and may impact patient access to medication | image credit: thanksforbuying - stock.adobe.com
September 3rd 2024

Timeframe of Drug Approval to Reimbursement Lags in US Compared With Europe

Kyle Munz
A comparative analysis investigating time from a drug's approval to insurance reimbursement found that the speed of this process in the US falls behind some European countries.
AJMC
September 3rd 2024

Beyond Average Spending: Distributional and Seasonal Commercial Insurance Trends, 2012-2021

Erin L. Duffy, PhD, MPH Sarah Green, BA Samantha Randall, BA Erin Trish, PhD
Analysis of 2012-2021 commercial claims demonstrates that spending growth was concentrated among the highest spenders and there was increasing subsidy across enrollees through cost-sharing design.
dr katherine baker
August 28th 2024

Dr Katherine Baker Emphasizes the Importance of Collaboration Between Physicians, Payers

Brooke McCormick
Katherine Baker, MD, MMHC, of Tennessee Oncology, highlights the need for physician-payer collaboration to tackle challenges and drive innovation in specialty care.
AQUA Registry Data Support Move to Value-Based Care in Urology
August 27th 2024

AQUA Registry Data Support Move to Value-Based Care in Urology

Laura Joszt, MA
National data sets and registries are able to provide outcomes data and process measures that testify to quality of care being delivered, said Matthew Nielsen, MD, FACS, chair, Department of Urology, University of North Carolina School of Medicine.
Kempton Presley, MPH, MS
August 26th 2024

Contributor: A Behavioral Science–Based Approach to Engaging the Highest-Risk, Hardest-to-Reach Patients

Kempton Presley, MPH, MS
Strategies to help Medicare Advantage plans boost Star Ratings by improving medication adherence among seemingly “unengageable” members
Pile of US dollars | Image Credit: Stillfx - stock.adobe.com
August 19th 2024

Reaction Mixed After CMS Unveils Negotiated Medicare Drug Prices

Brooke McCormick
Some groups praised CMS after it announced the 10 negotiated Medicare drug prices while others criticized its potential impacts on drug competition and development.
COA seal | Image : COA
August 16th 2024

Revised EOM Offers More Favorable Opportunities for Community Practices, Experts Say

Mary Caffrey
CMS logo | Image: HHS
August 16th 2024

Payment Cuts for Independent Oncologists Would Continue Under CMS’ Proposed 2025 Physician Fee Schedule

Mary Caffrey Giuliana Grossi
Federal Trade Commission | Image: Investopedia
August 15th 2024

In July, PBMs Find Themselves in the Federal Government Hot Seat

Mary Caffrey
"Medicare Advantage" written in an open notebook | Image Credit: dizain - stock.adobe.com
August 12th 2024

Medicare Advantage Hits 32.8M Enrollees, 54% of Spending

Brooke McCormick
Medicare Advantage (MA) enrollment has grown to 32.8 million in 2024, representing 54% of total Medicare spending, with significant variation in enrollment across states and counties.
Prescription for medication | Image credit: goodmanphoto - stock.adobe.com
August 2nd 2024

5 Things to Know About PBMs’ Influence on Drug Costs and Access

Rose McNulty
As pharmacy benefit managers (PBMs) come under increased scrutiny from regulatory agencies, here are 5 things to know about their role in the health care system.
AJMC
June 12th 2024

Hospital Strategies in Commercial Episode-Based Reimbursement

Scott E. Regenbogen, MD, MPH Shelytia Cocroft, PhD Sarah L. Krein, PhD, RN Michael P. Thompson, PhD
This study reports qualitative findings from an explanatory sequential mixed-methods investigation to understand hospitals’ approaches to a novel commercial episode-based reimbursement incentive program.
Bundled Payments Lead to Quality Improvements in Hospitals’ Skilled Nursing Facility Referral Networks
June 7th 2024

Bundled Payments Lead to Quality Improvements in Hospitals’ Skilled Nursing Facility Referral Networks

Sunny C. Lin, PhD, MS Russell J. Funk, PhD Andrew M. Ryan, PhD Karen E. Joynt Maddox, MD, MPH John M. Hollingsworth, MD, MS
The Bundled Payments for Care Improvement program was associated with improved quality of skilled nursing facilities in hospital referral networks for patients undergoing surgery for joint replacement.
12345678
...
9>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo